2008 promises to be an exciting year for KSX shareholders. They now have FDA approval and sales will start rolling out this year. The technology is outstanding and will revolutionize the way asthma is diagnosed. They have already signed one distribution agreement with others expected very soon.
The website is well worth a look.
http://www.karmelsonix.com.au/45003/Company-profile
